Drug intelligence / Profile preview

Erythrityl tetranitrate

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Sublingual
01

Overview

Erythrityl tetranitrate is a long-acting organic nitrate vasodilator used primarily for the prevention and long-term management of angina pectoris and coronary insufficiency. It acts by being converted to an active intermediate that activates guanylate cyclase, increasing cyclic guanosine monophosphate (cGMP) levels in vascular smooth muscle. This leads to protein kinase-dependent phosphorylation events, dephosphorylation of myosin light chains, reduced intracellular calcium, relaxation of smooth muscle cells, and vasodilation. Erythrityl tetranitrate is classified as an organic nitrate with pharmacological properties similar to nitroglycerin and is indicated for patients with frequent or recurrent anginal pain or during postcoronary convalescence[1][2][3][5].

Brand names
Cardilate
Other names
eritritol tetranitrateerythrol tetranitrate
02

Targets

NPR1 (Natriuretic peptide receptor 1)sGC (Soluble Guanylyl Cyclase)NPR2 (C-type Natriuretic Peptide Receptor B)

Beyond the preview

Go deeper on Erythrityl tetranitrate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Erythrityl tetranitrate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call